Clinical Trial Risk in Chronic Obstructive Pulmonary Disease: The Effects of Drug Class and Inclusion Criteria

Publisher： Karger

E-ISSN： 1423-0356|91|1|79-86

ISSN： 0025-7931

Source： Respiration, Vol.91, Iss.1, 2016-0, pp. : 79-86

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

What Proportion of Chronic Obstructive Pulmonary Disease Outpatients Is Eligible for Inclusion in Randomized Clinical Trials?

By  

Respiration, Vol. 87, Iss. 1, 2013-11 ,pp. : 11-17

Karger

Access to resources Recommend Favorite

Drugs in Clinical Development for Chronic Obstructive Pulmonary Disease

By  

Respiration, Vol. 72, Iss. 1, 2005-02 ,pp. : 105-112

Karger

Access to resources Recommend Favorite

Effect of the combination of two bronchodilators on breathlessness in patients with chronic obstructive pulmonary disease. A crossover clinical trial

By Sansores R.   Ramirez-Vanegas A.   Reddy C.   Mejia-Alfaro R.  

Archives of Medical Research, Vol. 34, Iss. 4, 2003-07 ,pp. : 292-297

Elsevier

Access to resources Recommend Favorite

The Effects of Gender on the Development of Chronic Obstructive Pulmonary Disease

By  

Respiration, Vol. 73, Iss. 3, 2006-05 ,pp. : 279-279

Karger

Access to resources Recommend Favorite

Acute Antiarrhythmic Effects of Bi-Level Positive Airway Pressure Ventilation in Patients with Acute Respiratory Failure Caused by Chronic Obstructive Pulmonary Disease: A Randomized Clinical Trial

By  

Respiration, Vol. 71, Iss. 2, 2004-03 ,pp. : 152-158

Karger

Access to resources Recommend Favorite